Optimal dosing of Jakafi was associated with improved efficacy and manageable safety in patients with myelofibrosis, ...

The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

I find strength and hope in the daffodils I grow, helping me face chronic lymphocytic leukemia with renewed determination.

I stay in the cancer social media world because it helps me cope, even when friends disappear and I’m left wondering if ...

The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal ...

Radiation therapy for gastrointestinal cancers is more precise and easier to tolerate due newer technologies and personalized ...

Dr. Petros Grivas discusses the importance of tailoring treatment decisions in bladder cancer based on data from three ...

U.S. medical centers are seeking FDA authorization for the compassionate use — or expanded access — of Namodenoson for ...

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

Dr. Nataliya Uboha sat down to discuss the early warning signs of esophageal cancer, as well as important key takeaways for ...